NL-OMON31272已完成不适用
Randomised, double-blind, placebo-controlled, single-dose, dose-escalation study of the safety, tolerability, and pharmacokinetics of Lu AA24493 in acute ischemic stroke - CEPO study 11767A
undbeck0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male or female patients, aged 50-90 years; clinical diagnosis of acute ischemic stroke; measurable stroke-related deficit, present at start of treatment; stable condition; treatment can be initiated 12 - 48 hours after onset of stroke symptoms; expected hospital stay of at least 72 hours after IMP administration. (for full inclusion criteria refer to study protocol, page 27)
排除标准
- •Patient has been treated with a thrombolytic within the previous 24 hours; score > 0 on the NIHSS consciousness item; life expectancy < 1 year from comorbid condition; pre-stroke mRS score > 1 (indicating previous disability); uncontrolled hypertension; history, clinical presentation or imaging evidence of various CNS abnormalities (for further specification, and full exclusion criteria refer to study protocol, page 28)
研究者
相似试验
尚未招募
2 期
Safety, tolerability and pharmacokinetics of SSTK-101 in healthy volunteersACTRN12624001064594SKYDD Biotechnology Pty Ltd38
进行中（未招募）
1 期
Influenza virus challenge study to test monocloncal antibody CT-P27 as a treatment for influenza (flu)MedDRA version: 16.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsInfluenzaEUCTR2013-004544-32-GBCelltrion, Inc
已完成
1 期
Safety, tolerability, PK and PD of SCO-094 in type 2 diabetic patientsType 2 diabetesJPRN-jRCT1080225227SCOHIA PHARMA, Inc.68
已完成
不适用
Double-blind, placebo-controlled, randomized, single-ascending dose study to investigate the tolerability, safety, pharmacokinetics, pharmacodynamics, absolute bioavailability, mass balance, and metabolism of ACT-541468 in healthy male subjectsSleep disordersSleeping disordersinsomniaNL-OMON41910Actelion Pharmaceuticals56
进行中（未招募）
1 期
Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMSEUCTR2016-003139-39-ESSpherium Biomed